A61K 36/41
Crassulaceae
Official title: Crassulaceae (Stonecrop family)
A61K36/41 (Crassulaceae) appears on 123 US grants and 249 published applications in this corpus.
Search patents in A61K- Granted patents
- 123
- Published applications
- 249
- Assignees
- 106
- Inventors
- 372
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 2 |
| 2003 | 2 | 6 |
| 2004 | 3 | 4 |
| 2005 | 1 | 6 |
| 2006 | 2 | 5 |
| 2007 | 1 | 4 |
| 2008 | 4 | 9 |
| 2009 | 3 | 5 |
| 2010 | 1 | 9 |
| 2011 | 2 | 6 |
| 2012 | 3 | 10 |
| 2013 | 8 | 8 |
| 2014 | 7 | 12 |
| 2015 | 6 | 13 |
| 2016 | 11 | 14 |
| 2017 | 7 | 8 |
| 2018 | 5 | 13 |
| 2019 | 4 | 10 |
| 2020 | 8 | 11 |
| 2021 | 9 | 21 |
| 2022 | 10 | 14 |
| 2023 | 8 | 12 |
| 2024 | 4 | 16 |
| 2025 | 8 | 17 |
| 2026 | 3 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Controlled release concentrate and suspensions including the same16 Jun 2026US 12,653,782 B2Nulixir Inc.
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid19 May 2026US 12,629,421 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Stimulant composition and process for making same24 Mar 2026US 12,582,659 B2All Labs, Inc.
- Controlled release core-shell particles and suspensions including the same2 Dec 2025US 12,485,091 B2Nulixir Inc.
- Composition for prevention, alleviation, or treatment of atopic dermatitis disease25 Nov 2025US 12,478,653 B2
- Adaptogenic, high-protein food product and method of making same8 Oct 2026US 2026/0305663 A1
- Fruit-based freeze-dried edibles8 Oct 2026US 2026/0306515 A1
- Physical performance aid27 Aug 2026US 2026/0248747 A1aXichem AB
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid6 Aug 2026US 2026/0224704 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Composition and Method to Correct Nutritional Deficiencies underlying Mood Disorder16 Jul 2026US 2026/0199356 A1Alfasigma S.P.A.
Most cited
By later US patents
- Allelic polygene diagnosis of reward deficiency syndrome and treatment99US 6,132,724 ACity of Hope National Medical Center · 2000
- Medicinal herbal compounds for the prevention and treatment of diabetes17US 6,551,627 B1Holomed Pharmaceuticals, Ltd. · 2003
- Rhodiola and used thereof15US 6,399,116 B12002
- Biologically active substances, method for obtaining and compositions containing them14US 6,737,086 B2Inovat S.A.R.L. · 2004
- Integrated neuromodulation system for mood enhancement of a living human subject14US 8,609,162 B2InVivo Beverages LLC · 2013